Cellogy supplies specialist consumables for advanced cell culture and provides consulting and services related to advanced intestinal and airway models, including monolayers, co-cultures and organoids.
Order the consumables you already use, or let us build and validate the cell model for you.
Cell culture inserts, multiwell plates, media and substrates for routine culture and advanced models alike.
See all products →Intestinal, airway, co-culture and organoid models: expert advice on building advanced and predictive models tailored for your need, or run as studies in our lab.
See models & services →Cellogy was founded by four scientists with years of hands-on experience building and using in vitro cell models, in academia and in industry. We started the company to give labs both the specialist consumables and the practical know-how needed to set up advanced intestinal and airway models that work.
Driton is a pharmacist (PhD from the University of Nottingham) and currently a Reader in Biotherapeutics Delivery at King's College London, where his research focuses on biological barriers to drug delivery and on building more predictive in vitro models, including organoids. He has published widely on intestinal and airway epithelial models and co-cultures, and works regularly with the pharmaceutical industry.
King's College London profile →Robyn holds a PhD in Pharmacy from the University of Nottingham and has six years of hands-on experience with cell-based models. She worked with intestinal and airway cell models at the University of Nottingham and has carried out ADME studies in industry.
Yunyue holds a PhD in Pharmaceutical Science from King's College London, where she is now a Postdoctoral Research Associate. Her research focuses on the oral delivery of biologics, with more than seven years of experience developing in vitro intestinal models, including healthy and diseased (e.g. IBD) epithelial co-culture models derived from cell lines or human organoids. She applies these models to investigate intestinal drug absorption, toxicity, and therapeutic efficacy.
Charlie holds a PhD and MSc in Pharmaceutical Science from King's College London, and a bachelor's degree in Pharmacy from London Metropolitan University.
He brings industry experience from European biotechnology and pharmaceutical companies, with expertise in nanomedicine, monoclonal antibodies and nucleic acid therapeutics. His background spans pharmaceutical R&D, product development and business development.
At Cellogy, he focuses on international strategic partnerships, product portfolio development and commercial expansion, bridging scientific expertise with business opportunities.
Ask for a quote, request samples, or tell us about the model you need.